Topotecan
Links shared publicly online about this topic
Topotecan on #MDlinx
mdlinx.com — “Topotecan on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 1, 2010 at 10:56 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A Phase I Study of Weekly Topotecan in Combination with Pemetrexed in Patients with Advanced Malignancies... http://bit.ly/9bOESm #medicine
NICE Recommends Topotecan For Cervical Cancer
medicalnewstoday.com — “The National Institute for Health and Clinical Excellence (NICE) has today (28 October) published final guidance recommending the use of topotecan in combination with cisplatin as a treatment opti” View full resource at medicalnewstoday.com
Most Recently Shared on November 3, 2009 at 11:28 pm By:
#HEALTH NICE Recommends Topotecan For Cervical Cancer - The National Institute for Health and Clinical Excellence (... http://ow.ly/15ZdYY
Oncology Medical News about Topotecan
mdlinx.com — “Myelotoxicity of oral topotecan in relation to treatment duration and dosage: A phase I study” View full resource at mdlinx.com
Most Recently Shared on December 24, 2009 at 9:32 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Heme/Onc: Myelotoxicity of oral topotecan in relation to treatment duration and dosage: A phase I study: Anti-Cancer Dru http://url4.eu/yVkg
FDA approves Hospira's topotecan for SCLC
news-medical.net — “Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of Topotecan Injection, the first solution formulation of the oncology drug approved in the United States.” View full resource at news-medical.net
Most Recently Shared on February 4, 2011 at 9:16 am By:
News-Medical.Net Health News and Oncology
Oncology News: FDA approves Hospira's topotecan for SCLC: Hospira, Inc., the world leader in generic injectable ... http://bit.ly/i5ASeN
Oncology Article | Topotecan Ovarian Neoplasms
mdlinx.com — “Topotecan weekly versus conventional 5-day schedule in patients with platinum-resistant ovarian cancer: A randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group” View full resource at mdlinx.com
Most Recently Shared on December 7, 2010 at 6:40 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Topotecan weekly versus conventional 5-day schedule in patients with platinum-resistant ovarian cancer... http://bit.ly/fVA9K7 #oncology
Oncology Medical News about Carboplatin Tamoxifen Topotecan
mdlinx.com — “Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors” View full resource at mdlinx.com
Most Recently Shared on February 9, 2010 at 11:40 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oncology Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, ... http://bit.ly/bWKiDD
Neurology Medical News about Carboplatin Tamoxifen Topotecan
mdlinx.com — “Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors” View full resource at mdlinx.com
Most Recently Shared on February 4, 2010 at 9:27 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Neuro: Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and car http://url4.eu/1JX8D
Sagent launches chemotherapy agent topotecan hydrochloride for injection
news-medical.net — “Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA approval and launch of its topotecan hydrochloride for injection, a chemotherapy agent, in conjunction with the innovator's patent expiry. Sagent's topotecan is available in 4 mg single-dose latex-free vials.” View full resource at news-medical.net
Most Recently Shared on December 3, 2010 at 9:10 am By:
News-Medical.Net Health News and Oncology
Oncology News: Sagent launches chemotherapy agent topotecan hydrochloride for injection: Sagent Pharmaceuticals,... http://bit.ly/hpKyDG
Another Confirmation of the Inactivity of Topotecan in Ovarian Cancer " J. Natl. Cancer Inst.
jnci.oxfordjournals.org — “Another Confirmation of the Inactivity of Topotecan in Ovarian Cancer " J. Natl. Cancer Inst.” View full resource at jnci.oxfordjournals.org
Most Recently Shared on October 26, 2010 at 2:08 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
Editorial on inactivity of topotecan: "Does the addition of topotecan to a platinum and taxane backbone improve... http://fb.me/IsmiXE4Q
Topotecan Tanks in Advanced Ovarian Cancer - QualityPoint Technologies
qualitypointtech.net — “The latest attempt to improve on platinum/taxane by adding topotecan was unsuccessful, as were 4 previous trials. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 13, 2010 at 8:37 pm By:
Topotecan Tanks in Advanced Ovarian Cancer: The latest attempt to improve on platinum/taxane by adding topotecan w... http://bit.ly/a2x1PW
Study finds inactivity of topotecan regimen to treat ovarian cancer
news-medical.net — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the National Cancer Institute.” View full resource at news-medical.net
Most Recently Shared on October 12, 2010 at 10:05 am By:
Study finds inactivity of topotecan regimen to treat ovarian cancer: Adding topotecan to carboplatin plus paclitax... http://bit.ly/djUgaz
Topotecan injection approved for small cell lung cancer (SCLC) - ONA
oncologynurseadvisor.com — “Hospira announced that the FDA has approved topotecan injection for the treatment of small cell lung cancer (SCLC) sensitive disease after failure of first-line chemotherapy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 4, 2011 at 4:21 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Topotecan injection approved for small cell lung cancer (SCLC) http://goo.gl/fb/wyHuh
Study finds inactivity of topotecan regimen to treat ovarian cancer
news-medical.net — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the National Cancer Institute.” View full resource at news-medical.net
Most Recently Shared on October 12, 2010 at 6:35 am By:
Study finds inactivity of topotecan regimen to treat ovarian cancer: Adding topotecan to carboplatin plus paclitax... http://bit.ly/9WfAV6
Topotecan injection approved for small cell lung cancer (SCLC) - MPR
empr.com — “Hospira announced that the FDA has approved topotecan injection for the treatment of small cell lung cancer (SCLC) sensitive disease after failure of first-line chemotherapy.” View full resource at empr.com
Most Recently Shared on February 4, 2011 at 4:17 pm By:
MPR News: Topotecan injection approved for small cell lung cancer (SCLC): Hospira announced that the FDA has app... http://bit.ly/erXh4e
Adding Topotecan to Standard Treatment for Ovarian Cancer Does Not Improve Progression-Free Survival " J. Natl. Cancer Inst.
jnci.oxfordjournals.org — “Adding Topotecan to Standard Treatment for Ovarian Cancer Does Not Improve Progression-Free Survival " J. Natl. Cancer Inst.” View full resource at jnci.oxfordjournals.org
Most Recently Shared on October 26, 2010 at 2:04 pm By:
J Nat'l Cancer Inst Medical Journal and Oncology
Topotecan does not improve overall survival in ovarian cancer. Press release and study. http://fb.me/CtSqCUOS
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Health Feed
Heath News & Information
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
